Applications Now Open for the $100,000 OCRA Health Equity Research Grant 2027

Application Deadline: March 25, 2026

Applications are now open for the OCRA Health Equity Research Grant 2027, a powerful funding opportunity for researchers dedicated to improving outcomes for women affected by ovarian and related gynecologic cancers. Offered by the Ovarian Cancer Research Alliance (OCRA), this grant seeks to advance scientific discovery that tackles one of the most urgent issues in modern healthcare.

Ovarian cancer remains one of the deadliest cancers affecting women worldwide. Despite progress in diagnosis and treatment, survival rates vary dramatically depending on race, income, and geography. This disparity is not just a matter of biology but of access, equity, and social determinants of health.

Through this Health Equity Research Grant, OCRA is investing in projects that break down barriers to care, improve diagnostic accuracy, and develop solutions that ensure every patient — regardless of background — has access to life-saving treatment and support.

This initiative represents a critical step toward building an inclusive healthcare future, where innovation and compassion go hand in hand.

About the OCRA Health Equity Research Grant

The OCRA Health Equity Research Grant 2027 is a dedicated funding program that supports innovative scientific projects focused on understanding and addressing health disparities in ovarian and related gynecologic cancers.

Backed by OCRA, the leading nonprofit organization dedicated to eradicating ovarian cancer through research, advocacy, and patient support, this grant embodies the organization’s mission to ensure equitable healthcare access for all.

Over the years, OCRA has invested millions of dollars into cutting-edge ovarian cancer research. This particular program highlights its growing commitment to health equity, encouraging scientists to explore how social, cultural, economic, and environmental factors influence cancer outcomes.

The program aims to:

Identify and address social, cultural, and economic factors that drive disparities in ovarian cancer diagnosis and treatment.
Improve access to quality care, advanced diagnostic tools, and treatment options for underserved communities.
Examine how racial, ethnic, socioeconomic, or geographic variables impact survival and disease progression.
Explore genetic or molecular differences contributing to disparities in cancer outcomes.
Develop targeted, evidence-based interventions that promote equitable care.

By funding high-impact research, OCRA hopes to generate knowledge that not only advances science but also shapes real-world health policy and clinical practice.

Benefits – What Successful Applicants Receive

Successful applicants to the OCRA Health Equity Research Grant 2027 will gain substantial support for their research initiatives.

Key benefits include:

Funding of up to $100,000 per year for two years (totaling $200,000 per project).
Research funding granted directly to the Principal Investigator’s institution, supporting both new and ongoing initiatives that align with OCRA’s equity objectives.
Opportunities for publication in peer-reviewed journals and recognition at international scientific conferences.
Access to OCRA’s global research network, fostering collaboration, mentorship, and visibility within the cancer research community.
Potential for follow-up funding, as successful grantees often become eligible for larger or continued grants based on research impact.

The funding period begins February 1, 2027, and projects will be expected to produce measurable results, share progress reports, and contribute to the collective body of ovarian cancer research.

Eligibility Criteria

To ensure a fair and inclusive selection process, OCRA has designed broad eligibility parameters. Applicants must:

Hold a doctoral degree (PhD, ScD, MD, or equivalent) at the time of application.
Be eligible to serve as a Principal Investigator (PI) at their home institution.
Apply through an accredited academic or nonprofit research institution, including universities, research hospitals, or recognized scientific research facilities.
Be at any career stage — early, mid, or senior-level researchers are all welcome.
Be of any nationality — there are no citizenship restrictions.
Submit only one Letter of Intent (LOI) per grant cycle across all OCRA funding opportunities.

Not eligible:
For-profit entities, consulting companies, non-research organizations, or nonprofits not directly conducting the proposed research.

Application Process & Key Dates

Interested applicants must first submit a Letter of Intent (LOI) before being invited to submit a full proposal.

Important Dates:

Post Date: February 26, 2026
Deadline for LOI Submission: March 25, 2026
Funding Start Date: February 1, 2027

Applications will be reviewed by an expert committee based on:

Scientific merit and originality
Relevance to ovarian cancer equity
Feasibility and methodological soundness
Potential for impact, publication, and further funding

Why You Should Apply – and How to Stand Out

This grant is more than funding — it’s a chance to lead change. If your research aims to uncover why health inequities persist and how to eliminate them, this is your opportunity to make a global impact.

To strengthen your application:

Center Equity: Clearly connect your research proposal to the theme of health equity and explain its real-world implications.
Show Innovation: Highlight how your project challenges current assumptions or introduces new methods.
Demonstrate Feasibility: Provide a realistic plan, timeline, and measurable outcomes.
Highlight Collaboration: Show potential partnerships across disciplines, communities, or institutions.
Impact Beyond Academia: Explain how your findings could influence patient outcomes, clinical practice, or healthcare policy.

Remember — reviewers are not only looking for strong science but also for commitment to inclusion, creativity, and social impact.

Why This Grant Matters Globally

Ovarian cancer affects over 300,000 women annually, yet awareness, diagnosis, and treatment options remain uneven across the world. In many African, Latin American, and Asian countries, delayed diagnosis and limited access to specialized care result in lower survival rates.

Programs like OCRA’s Health Equity Research Grant are vital because they drive global conversations about fairness in healthcare — ensuring that breakthroughs benefit all women, not just those in wealthy regions. For African researchers and institutions, this grant is a chance to bring local realities into global research discussions and advocate for data-driven change.

Conclusion

Health equity in ovarian cancer isn’t just a research goal — it’s a moral imperative. The OCRA Health Equity Research Grant 2027 offers scientists, clinicians, and institutions the resources to bridge gaps and create lasting impact in women’s health worldwide.

If you’re passionate about advancing cancer equity, start your application today. Don’t wait until the deadline — early preparation gives you a competitive edge.

For more information and to apply, CLICK HERE

Grants global opportunities